Scholar Rock Holding (SRRK) Non Operating Income (2017 - 2026)

Scholar Rock Holding (SRRK) recorded quarterly Non Operating Income of -$790000.0 in Q1 2026, down 1195.08% quarter-over-quarter from -$61000.0 in Q4 2025, and down 1695.45% on a YoY basis from $49515.7 in Q1 2025.

Scholar Rock Holding (SRRK) Non Operating Income (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Non Operating Income history runs 10 years deep, the most recent figure standing at -$790000.0 for Q1 2026.

  • In Q1 2026, Non Operating Income fell 1695.45% year-over-year to -$790000.0; the TTM figure through Mar 2026 stood at $1.2 million (down 69.61% YoY), while the FY2025 annual figure was -$301000.0, down 105.23% from the prior year.
  • Non Operating Income was -$790000.0 for Q1 2026 at Scholar Rock Holding, down from -$61000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $2.9 million in Q4 2024 to a low of -$1.0 million in Q1 2022.
  • Historically, Non Operating Income has averaged $700529.4 across 5 years, with a median of $990000.0 in 2024.
  • The sharpest annual moves came in 2022 and 2026: Non Operating Income jumped 313.27% in 2022, then tumbled 1695.45% in 2026.
  • A 5-year view of Non Operating Income shows it stood at $1.2 million in 2022, then jumped by 62.49% to $1.9 million in 2023, then surged by 52.31% to $2.9 million in 2024, then tumbled by 102.1% to -$61000.0 in 2025, then plunged by 1195.08% to -$790000.0 in 2026.
  • The last three Non Operating Income figures came in at -$790000.0 (Q1 2026), -$61000.0 (Q4 2025), and -$69000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 5.75 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 444,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - 9.35 Mn
10 Scholar Rock Holding 6.03 Bn 5.55 Bn - -790,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -790,000.00
Dec 31, 2025 -61,000.00
Sep 30, 2025 -69,000.00
Jun 30, 2025 2.08 Mn
Mar 31, 2025 -44,000.00
Dec 31, 2024 2.90 Mn
Sep 30, 2024 -38,000.00
Jun 30, 2024 990,000.00
Mar 31, 2024 1.57 Mn
Dec 31, 2023 1.91 Mn
Sep 30, 2023 1.31 Mn
Jun 30, 2023 1.16 Mn
Mar 31, 2023 1.13 Mn
Dec 31, 2022 1.17 Mn
Sep 30, 2022 565,000.00
Jun 30, 2022 -853,000.00
Mar 31, 2022 -1.02 Mn
Dec 31, 2021 -550,000.00
Sep 30, 2021 -430,000.00
Jun 30, 2021 -434,000.00